(Press-News.org) According to the World Health Organisation, tuberculosis accounts for one in three deaths among people living with HIV. In fact, even when receiving effective antiretroviral treatment, HIV-positive individuals are 15 to 30 times more likely to contract tuberculosis than HIV-uninfected people.
In a study to be published in PLOS Pathogens, the CNRS-led research team1 highlights the key role played by Tat2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon. Studies conducted on human cells and zebrafish larvae revealed that this protein blocks the cell defence mechanism known as autophagy, thereby promoting the survival and multiplication of the bacterium responsible for tuberculosis – Mycobacterium tuberculosis – in target cells3.
These findings shed new light on the synergy between HIV and tuberculosis and pave the way for the development of innovative therapeutic strategies. Although the Tat protein remains difficult to target at present, treatments aimed at restoring the autophagy mechanism could be developed to better protect patients.
From l’Institut de recherche en infectiologie de Montpellier (CNRS/Université de Montpellier), Laboratory of Pathogens and Host Immunity (CNRS/Inserm/Université de Montpellier), l’Institut de pharmacologie et biologie structurale (CNRS/Université de Toulouse) and l’Institut interdisciplinaire de neurosciences (CNRS/Université de Bordeaux).
Transactivator of transcription.
Known as macrophages, these cells belong to the white blood cell group. Their main role is to destroy cellular debris and pathogens throughout the body. END
Tuberculosis vulnerability of people with HIV: a viral protein implicated
2025-09-18
ELSE PRESS RELEASES FROM THIS DATE:
Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living
2025-09-18
Through a collaboration between U.S. and Kenyan researchers and Turkana communities of northern Kenya, scientists have uncovered key genetic adaptations underlying survival in hot and dry environments, revealing how natural selection has enabled this pastoralist population to thrive in a challenging landscape.
A new analysis of Turkana genomes through a collaboration between US and Kenyan institutions shows how the activity of key genes has changed over millennia to allow them to thrive in extreme desert conditions. The comprehensive study, published in Science, reveals how the Turkana ...
Decoding the selfish gene, from evolutionary cheaters to disease control
2025-09-18
Decoding the selfish gene, from evolutionary cheaters to disease control
Scientists from the University of Sheffield have uncovered how to potentially control harmful insect populations by studying a "selfish gene" that manipulates inheritance
The new research focuses on meiotic drive, a process where a selfish gene gives itself a better chance of being passed on to the next generation, disrupting the normal 50/50 inheritance pattern
By studying the Malaysian stalk-eyed fly, researchers discovered that a selfish gene can damage rival sperm carrying a Y chromosome, leading to a population ...
Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies
2025-09-18
Postpartum hemorrhage, severe bleeding after childbirth, is a leading cause of maternal mortality around the world. But many of these deaths can be prevented—and a real-time blood-monitoring technology called viscoelastic testing (VET) could play a crucial role. Though used in parts of Europe, VET is not yet a standard part of maternity care in the United States.
A new sweeping review from the Southern California Evidence Review Center, part of the Keck School of Medicine of USC, brings U.S. hospitals a step closer ...
Inspired by bacteria’s defense strategies
2025-09-18
Targeted editing of genetic information has advanced at an extraordinary pace in recent years. Tools such as the CRISPR-Cas9 “gene scissors” and base editing—a technique that makes precise, single-letter changes to DNA without cutting it—have already become standard in research and clinical development. These technologies are being used to treat genetic disorders, enhance crop resistance, and engineer bacteria for biotechnological purposes.
Turning the battle between bacteria and viruses into scientific progress
Researchers at the Helmholtz Institute ...
Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma
2025-09-18
Rakesh Jain, PhD, director of the Edwin Steele Laboratories for Tumor Biology in the Department of Radiation Oncology at Massachusetts General Hospital and Andrew Werk Professor of Radiation Oncology at Harvard Medical School, is senior and corresponding author of a new paper in PNAS, “Wnt Inhibition Alleviates Resistance to Anti-PD1 Therapy and Improves Anti-Tumor Immunity in Glioblastoma."
Q: How would you summarize your study for a lay audience?
Brain tumor patients with glioblastoma (GBM) face extremely limited treatment options and show poor responses to current immunotherapies. New treatment strategies are ...
University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children
2025-09-18
Key Takeaways
University of Houston College of Optometry professor is co-leading a national $25 million NIH-funded clinical trial to delay the development of myopia.
Researchers are testing whether low-concentrate atropine drops can delay onset of myopia in children.
The more nearsighted someone becomes, the greater their risk of sight-threatening complications later as an adult.
The University of Houston is co-leading a national study, the first of its kind in the United States, ...
NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer
2025-09-18
PHILADELPHIA, PA – The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed accrual and met its accrual milestone of 2,478 patients approximately two years earlier than the trial’s anticipated accrual completion date.
“The incidence of men receiving high-risk prostate cancer diagnoses is on the increase in recent years. The PREDICT-RT study was designed to improve quality of life and outcomes for these patients while tailoring treatments to meet each individual’s needs based on their Decipher Prostate Genomic Classifier ...
Taking aim at nearsightedness in kids before it’s diagnosed
2025-09-18
COLUMBUS, Ohio – For the first time, researchers are leading a national study to see if the onset of nearsightedness can be delayed – and consequently reduced in magnitude over a lifetime – with the use of eyedrops in young children.
Scientists at The Ohio State University and the University of Houston have received two grants from the National Institutes of Health totaling $25 million to test daily drops of atropine as a nearsightedness preventive therapy in children age 6-11 years old.
“The more nearsightedness you have, the ...
With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike
2025-09-18
As infants, humans naturally learn new words and their associations—like the fact that forks are related to bowls because both are used to consume food. In a study publishing in the Cell Press journal Current Biology on September 18, a team of animal behavior experts demonstrate that dogs can categorize objects by function, too. In a series of playful interactions with their owners, a group of Gifted Word Learner (GWL) dogs were able to distinguish between toys used for tugging versus fetching, even when the toys in question didn’t share any obvious physical ...
Three deadliest risk factors of a common liver disease identified in new study
2025-09-18
LOS ANGELES — More than a third of the world’s population is affected by metabolic dysfunction-associated steatotic liver disease, or MASLD, the most common chronic liver disease in the world.
MASLD occurs when fat builds up in the liver and is associated with one or more of five conditions: obesity, Type 2 diabetes, high blood pressure, high blood sugar and low HDL cholesterol, known as “good” cholesterol. These conditions are characterized as cardiometabolic risk ...